Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Qualigen Therapeutics Q1 EPS $(0.78) Up From $(1.20) YoY, Sales $1.61M Miss $2.00M Estimate

Author: Benzinga Newsdesk | May 16, 2023 08:06am
Qualigen Therapeutics (NASDAQ:QLGN) reported quarterly losses of $(0.78) per share. This is a 35 percent increase over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $1.61 million which missed the analyst consensus estimate of $2.00 million by 19.64 percent. This is a 122.59 percent increase over sales of $722.03 thousand the same period last year.

Posted In: QLGN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist